In our study, UCH-L1 showed a strong correlation with clinical signs of parkinsonism in MPAN patients and dystonia in PKAN patients, both indicating the severity of disease progression. This evidence concerns the gene UCHL1 and pantothenate kinase-associated neurodegeneration.